Unknown

Dataset Information

Identification of volatile metabolites produced from levodopa metabolism by different bacteria strains of the gut microbiome.


ABSTRACT: Interspecies pathways in the gut microbiome have been shown to metabolize levodopa, the primary treatment for Parkinson's disease, and reduce its bioavailability. While the enzymatic reactions have been identified, the ability to establish the resulting macromolecules as biomarkers of microbial metabolism remains technically challenging. In this study, we leveraged an untargeted mass spectrometry-based approach to investigate volatile organic compounds (VOCs) produced during levodopa metabolism by Enterococcus faecalis, Clostridium sporogenes, and Eggerthella lenta. We cultured these organisms with and without their respective bioactive metabolites and detected levodopa-induced shifts in VOC profiles. We then utilized bioinformatics to identify significant differences in 2,6-dimethylpyrazi

SUBMITTER: Pennington T 

PROVIDER: S-EPMC11245815 | biostudies-literature | 2024 Jul

REPOSITORIES: biostudies-literature